Live Webinar: From MedChem to GMP: DS & DP Choices That Shape IND Timelines

Scaling up from medicinal chemistry to clinical manufacturing can introduce hidden risks that impact timelines, API quality, and regulatory success.

In this webinar, we explore the critical challenges faced when transitioning from early medicinal chemistry routes to scale, highlighting how overlooked decisions around impurity control, solid form, and process design can lead to costly delays and rework.

Through a series of decision-focused case studies, our experts will demonstrate how integrating drug substance and formulation development early can identify risks sooner, reduce timeline creep, and support confident progression to IND and first-in-human studies.

Register now using the link of this page to gain practical insights into the key decisions that shape your development programme, ultimately learning how to keep your pathway to clinic on track.